IRIS
SMIRNE, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.478
NA - Nord America 2.216
AS - Asia 1.716
SA - Sud America 262
AF - Africa 55
Totale 6.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.160
SG - Singapore 802
IE - Irlanda 603
IT - Italia 400
DE - Germania 365
SE - Svezia 314
CN - Cina 273
HK - Hong Kong 245
BR - Brasile 215
UA - Ucraina 197
RU - Federazione Russa 161
VN - Vietnam 154
FR - Francia 134
FI - Finlandia 124
IN - India 82
GB - Regno Unito 66
KR - Corea 53
ID - Indonesia 39
CA - Canada 35
BJ - Benin 25
AT - Austria 22
CZ - Repubblica Ceca 20
AR - Argentina 19
PL - Polonia 18
ZA - Sudafrica 17
BD - Bangladesh 16
BE - Belgio 16
MX - Messico 12
NL - Olanda 11
IR - Iran 9
TR - Turchia 9
CL - Cile 8
EC - Ecuador 8
JP - Giappone 8
ES - Italia 6
KE - Kenya 6
IQ - Iraq 5
CO - Colombia 4
EG - Egitto 4
LT - Lituania 4
AL - Albania 3
CH - Svizzera 3
PH - Filippine 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
JM - Giamaica 2
JO - Giordania 2
MK - Macedonia 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
KW - Kuwait 1
LV - Lettonia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
Totale 6.727
Salva come PNG Salva come JPEG
Città #
Dublin 603
Jacksonville 359
Hong Kong 243
Dearborn 166
Chandler 152
Ashburn 151
Singapore 140
Beijing 129
Wilmington 90
Ann Arbor 81
Los Angeles 77
Piemonte 76
Lawrence 71
Princeton 71
Moscow 58
San Mateo 58
Milan 54
Ho Chi Minh City 53
Seoul 53
Novara 45
Buffalo 43
Munich 42
Andover 41
Hanoi 32
Jakarta 29
São Paulo 29
New York 28
Turin 28
Cotonou 25
Nuremberg 25
Santa Clara 21
Brno 20
Helsinki 20
Frankfurt am Main 19
Houston 19
Brooklyn 17
Dallas 17
Nanjing 17
Brussels 16
Dong Ket 16
Boardman 15
Warsaw 15
Atlanta 13
Denver 13
Hefei 13
Johannesburg 13
Woodbridge 13
Redondo Beach 12
Chennai 11
London 11
Norwalk 11
Stockholm 11
Chicago 10
Düsseldorf 10
Falkenstein 10
Poplar 10
Montreal 9
Philadelphia 9
Seattle 9
Toronto 9
Bremen 8
Haiphong 8
Tianjin 8
Tokyo 8
Turku 8
Boston 7
Grafing 7
Manchester 7
Rome 7
Strasbourg 7
Vercelli 7
Alessandria 6
Augusta 6
Berlin 6
Da Nang 6
Fairfield 6
Jinan 6
Kunming 6
Nairobi 6
Brasília 5
City of London 5
Guangzhou 5
Monmouth Junction 5
Monza 5
Mumbai 5
Naples 5
Palermo 5
Phoenix 5
Porto Alegre 5
Salvador 5
San Francisco 5
Vienna 5
Bologna 4
Bắc Ninh 4
Charlotte 4
Fortaleza 4
Fuzhou 4
Guayaquil 4
Magenta 4
Mexico City 4
Totale 3.688
Salva come PNG Salva come JPEG
Nome #
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 260
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 207
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 204
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 149
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 138
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 119
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 116
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 110
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 105
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 103
Diagnostic value of FibroTest with normal serum aminotransferases 102
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 102
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 100
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 100
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential 99
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 99
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 99
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 93
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells 92
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 91
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 91
The surgical treatment of lung metastases. The prognostic factors and the indications for the surgical approach 90
Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2 90
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 90
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 90
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 89
ACE genotype, body weight changes and target organ damage in renal transplant recipients 89
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 88
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma 87
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 87
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 86
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 85
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C 84
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: A case report 83
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 81
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 78
Acquired post partum hemophilia 77
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 77
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 76
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 76
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 73
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response 73
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver. 72
Vascular endothelial growth factor. From basic research to clinical application 72
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose 72
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 70
Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C 70
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 70
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 69
Use, misuse and abuse of diuretics 69
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 66
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 65
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 64
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 64
Chlamydia trachomatis prevalence in North-West Italy 64
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 64
Imatinib mesylate for the treatment of solid tumours: Recent trials and future directions 64
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 64
Plasma Extracellular Vesicles from Preeclamptic Patients Trigger a Detrimental Crosstalk Between Glomerular Endothelial Cells and Podocytes Involving Endothelin-1 62
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 61
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients 60
Sexually transmitted diseases and pelvic inflammatory disease 58
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 58
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 58
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 57
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 57
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 56
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application 56
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study 54
KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes 53
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 52
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 52
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 52
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas. 51
The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects 51
Imatinib mesilate: New perspectives in the treatment of solid tumours 51
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 50
Imatinib mesylate: new perspectives in the treatment of solid tumours 49
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential 48
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 46
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? 45
Clinical Features and Outcomes of Patients with Full Spectrum of COVID-19 Severity and Concomitant Herpesvirus Reactivation 45
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection 40
Unveiling the Mystery of Adult-Onset Still’s Disease: A Compelling Case Report 40
Evaluation of plasma interferon alpha concentration as a marker of disease severity in human psoriasis 35
The Impact of the G6PD Gene Mutations in Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals: A Multicenter Observational Study 34
Totale 6.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021292 0 0 0 0 0 26 72 4 73 20 72 25
2021/2022570 12 22 93 58 35 15 64 19 48 28 67 109
2022/20231.273 141 55 67 33 65 130 27 73 618 6 44 14
2023/2024490 35 54 35 15 87 8 93 17 14 11 42 79
2024/20251.406 25 7 45 20 26 70 160 86 249 135 218 365
2025/20261.521 153 151 250 541 394 32 0 0 0 0 0 0
Totale 6.838